1. |
朱厚玲, 邱红渝. 抗基底膜抗体肾炎伴抗中性粒细胞胞浆抗体阳性的新月体肾小球肾炎一例. 华西医学, 2017, 32(5): 795-796.
|
2. |
Zhang YY, Tang Z, Chen DM, et al. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis. BMC Nephrol, 2014, 15: 128.
|
3. |
蒋欣欣, 冯剑, 胡卫民, 等. 双重滤过血浆置换与血浆置换治疗重症自身免疫性疾病的比较研究. 中华危重症医学杂志: 电子版, 2010, 3(2): 84-89.
|
4. |
Hanafusa N, Kondo Y, Suzuki M, et al. Double filtration plasmapheresis can decrease factor XIII Activity. Ther Apher Dial, 2007, 11(3): 165-170.
|
5. |
Jagdish K, Jacob S, Varughese S, et al. Effect of double filtration plasmapheresis on various plasma components and patient safety: a prospective observational cohort study. Indian J Nephrol, 2017, 27(5): 377-383.
|
6. |
Chuang YC, Lee CT, Chen JB, et al. Experience in the treatment of myasthenia gravis with double filtration plasmapheresis. Chang Gung Med J, 2000, 23(2): 80-86.
|
7. |
李彩凤. 双重滤过血浆置换与全血浆置换治疗神经系统自身免疫性疾病的疗效观察//2016 年中国中西医结合学会肾脏疾病专业委员会学术年会论文摘要汇编. 北京: 中国中西医结合学会肾脏疾病专业委员会, 2016: PU-410.
|
8. |
Yeh JH, Chen WH, Huang KM, et al. Prethymectomy plasmapheresis in myasthenia gravis. J Clin Apher, 2005, 20(4): 217-221.
|
9. |
Matsuda Y, Tsuda H, Takasaki Y, et al. Double filtration plasmapheresis for the treatment of a rheumatoid arthritis patient with extremely high level of c-reactive protein. Ther Apher Dial, 2004, 8(5): 404-408.
|
10. |
Jiang X, Lu M, Ying Y, et al. A case report of double-filtration plasmapheresis for the resolution of refractory chronic urticaria. Ther Apher Dial, 2008, 12(6): 505-508.
|
11. |
Szpirt WM, Heaf JG, Petersen J. Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener’s granulomatosis--a clinical randomized controlled trial. Nephrol Dial Transplant, 2011, 26(1): 206-213.
|
12. |
De Lind Van Wijngaarden RA, Hauer HA, Wolterbeek R, et al. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol, 2007, 18(7): 2189-2197.
|
13. |
Jayne DR, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol, 2007, 18(7): 2180-2188.
|
14. |
Gong D, Ji D, Xu B, et al. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy. Ther Apher Dial, 2013, 17(1): 93-98.
|
15. |
Chen Y, Yang L, Li K, et al. Double filtration plasmapheresis in the treatment of antineutrophil cytoplasmic autoantibody associated vasculitis with severe renal failure: a preliminary study of 15 patients. Ther Apher Dial, 2016, 20(2): 183-188.
|
16. |
Li M, Wang Y, Qiu Q, et al. Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis. J Clin Apher, 2015, 31(4): 375-380.
|
17. |
王慧, 郑智勇. C3 肾小球病研究进展. 临床与实验病理学杂志, 2015, 31(4): 439-442.
|
18. |
谢轲楠, 陈劲松. 血浆分离技术在肾移植中的应用. 肾脏病与透析肾移植杂志, 2014, 23(6): 573-576.
|